Showing results (281-290 of 1,188) with videos related to

Sort By:
Pageof 119
Leukemia Research|January 18, 2003
Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemiaEfrosyni Apostolidou, Elihu Estey, Jorge Cortes, et al.
Malaria Journal|July 25, 2016
A cluster randomized trial comparing deltamethrin and bendiocarb as insecticides for indoor residual spraying to control malaria on Bioko Island, Equatorial GuineaJohn Bradley, Dianna Hergott, Guillermo Garcia, et al.
Cancer|October 30, 2003
Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phaseJorge Medina, Hagop Kantarjian, Moshe Talpaz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 24, 2009
Screening for CKD and cardiovascular disease risk factors using mobile clinics in Jalisco, MexicoJose Alfonso Gutierrez-Padilla, Martha Mendoza-Garcia, Salvador Plascencia-Perez, et al.
Applied Optics|April 5, 2017
Error compensation in a pointing system based on Risley prismsBeethoven Bravo-Medina, Marija Strojnik, Guillermo Garcia-Torales, et al.
Malaria Journal|April 22, 2015
Outdoor biting by Anopheles mosquitoes on Bioko Island does not currently impact on malaria controlJohn Bradley, Jo Lines, Godwin Fuseini, et al.
Haematologica|July 14, 2022
Improved outcomes with "7+3" induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial dataMegan Othus, Guillermo Garcia-Manero, John E Godwin, et al.
Cancer Letters|May 3, 2016
Metabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3/ITD mutationAmin Huang, Huai-Qiang Ju, Kaiyan Liu, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 17, 2019
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III TrialGuillermo Garcia-Manero, Antonio Almeida, Pierre Fenaux, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2012
Prognostic factors associated with disease progression and overall survival in patients with myelodysplastic syndromes treated with decitabineElias Jabbour, Guillermo Garcia-Manero, Farhad Ravandi, et al.
Pageof 119